Anxiety and depression associated with caffeinism among psychiatric inpatients
The DOI matches its Crossref record.
Abstract
Among 83 hospitalized adult psychiatric patients, 22% reported being high caffeine consumers (750 mg or more per day); these patients scored significantly greater on the State-Trait Anxiety Index and the Beck Depression Scale than moderate and low consumers. High consumers described significantly more clinical symptoms, felt that their physical health was not as good, and reported greater use of sedative-hypnotics and minor tranquilizers. Since caffeine modifies catecholamine levels, inhibits phosphodiesterase breakdown of cyclic AMP, and sensitizes receptor sites, association of caffeinism with both anxiety and depressive symptoms is possible.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Nehlig, A., Daval, J.-L., & Debry, G. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90012-b · Cited by 1,461
The role of adenosine and its nucleotides in central synaptic transmission
Phillis, J. W., & Wu, P. H. (1981) · Progress in Neurobiology · doi:10.1016/0301-0082(81)90014-9 · Cited by 764
Juliano, L. M., & Griffiths, R. R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2000-x · Cited by 581
Increased Anxiogenic Effects of Caffeine in Panic Disorders
Charney, D. S. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790260027003 · Cited by 428
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419
Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications
Carrillo, J. A., & Benitez, J. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039020-00004 · Cited by 364
Caffeine physical dependence: a review of human and laboratory animal studies
Griffiths, R. R., & Woodson, P. P. (1988) · Psychopharmacology · doi:10.1007/bf00212836 · Cited by 276
Coffee, Caffeine, and Risk of Depression Among Women
Lucas, M. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.393 · Cited by 270
“In individuals with a particular genetic background(34) or who are otherwise sensitive, caffeine might induce sleep disturbances and insomnia(35) or anxiogenic effects.(20,36,37) It is possible that sleep-sensitive or anxious women are aware of the stimulatory effects of caffeine and lower their consumption accordingl…”
BackgroundApplications of the Beck Depression Inventory
Steer, R. A., Beck, A. T., & Garrison, B. (1986) · Assessment of Depression · doi:10.1007/978-3-642-70486-4_13 · Cited by 261
Sweetened beverages, coffee, and tea and depression risk among older US adults
Guo, X., Park, Y., Freedman, N. D., Sinha, R., Hollenbeck, A. R., Blair, A., & Chen, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094715 · Cited by 161
Caffeine Withdrawal: A Parametric Analysis of Caffeine Dosing Conditions
Evans, S. M., & Griffiths, R. R. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38135-2 · Cited by 145
Lucas, M., O’Reilly, E. J., Pan, A., Mirzaei, F., Willett, W. C., Okereke, O. I., & Ascherio, A. (2014) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.795243 · Cited by 103
Caffeine-induced psychiatric manifestations: a review
Wang, H. R., Woo, Y. S., & Bahk, W.-M. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000076 · Cited by 45
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1978-08-01
- Volume
- 135
- Issue
- 8
- Pages
- 963-966
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2416160455
- Cited by
- 189
- References
- 0
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.